Literature DB >> 17403684

Post-translational methylation of high mobility group box 1 (HMGB1) causes its cytoplasmic localization in neutrophils.

Ichiaki Ito1, Jutarou Fukazawa, Michiteru Yoshida.   

Abstract

High mobility group box 1 (HMGB1) protein plays multiple roles in transcription, replication, and cellular differentiation. HMGB1 is also secreted by activated monocytes and macrophages and passively released by necrotic or damaged cells, stimulating inflammation. HMGB1 is a novel antigen of anti-neutrophil cytoplasmic antibodies (ANCA) observed in the sera of patients with ulcerative colitis and autoimmune hepatitis, suggesting that HMGB1 is secreted from neutrophils to the extracellular milieu. However, the actual distribution of HMGB1 in the cytoplasm of neutrophils and the mechanisms responsible for it are obscure. Here we show that HMGB1 in neutrophils is post-translationally mono-methylated at Lys42. The methylation alters the conformation of HMGB1 and weakens its DNA binding activity, causing it to become largely distributed in the cytoplasm by passive diffusion out of the nucleus. Thus, post-translational methylation of HMGB1 causes its cytoplasmic localization in neutrophils. This novel pathway explains the distribution of nuclear HMGB1 to the cytoplasm and is important for understanding how neutrophils release HMGB1 to the extracellular milieu.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17403684     DOI: 10.1074/jbc.M608467200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  90 in total

Review 1.  HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease.

Authors:  Helena Erlandsson Harris; Ulf Andersson; David S Pisetsky
Journal:  Nat Rev Rheumatol       Date:  2012-01-31       Impact factor: 20.543

Review 2.  Regulation of Posttranslational Modifications of HMGB1 During Immune Responses.

Authors:  Yiting Tang; Xin Zhao; Daniel Antoine; Xianzhong Xiao; Haichao Wang; Ulf Andersson; Timothy R Billiar; Kevin J Tracey; Ben Lu
Journal:  Antioxid Redox Signal       Date:  2016-02-05       Impact factor: 8.401

Review 3.  Post-translational modifications of high mobility group box 1 and cancer.

Authors:  Seidu A Richard; Yuanyuan Jiang; Lu Hong Xiang; Shanshan Zhou; Jia Wang; Zhaoliang Su; Huaxi Xu
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

4.  HMGB1 Binds to Lipoteichoic Acid and Enhances TNF-α and IL-6 Production through HMGB1-Mediated Transfer of Lipoteichoic Acid to CD14 and TLR2.

Authors:  Man Sup Kwak; Mihwa Lim; Yong Joon Lee; Hyun Sook Lee; Young Hun Kim; Ju Ho Youn; Ji Eun Choi; Jeon-Soo Shin
Journal:  J Innate Immun       Date:  2015-02-05       Impact factor: 7.349

Review 5.  High mobility group proteins and their post-translational modifications.

Authors:  Qingchun Zhang; Yinsheng Wang
Journal:  Biochim Biophys Acta       Date:  2008-05-10

6.  SIRT6-PARP1 is involved in HMGB1 polyADP-ribosylation and acetylation and promotes chemotherapy-induced autophagy in leukemia.

Authors:  Qian Kong; Yunyao Li; Qixiang Liang; Jianwei Xie; Xinyu Li; Jianpei Fang
Journal:  Cancer Biol Ther       Date:  2020-01-13       Impact factor: 4.742

Review 7.  Location is the key to function: HMGB1 in sepsis and trauma-induced inflammation.

Authors:  Meihong Deng; Melanie J Scott; Jie Fan; Timothy R Billiar
Journal:  J Leukoc Biol       Date:  2019-04-04       Impact factor: 4.962

Review 8.  The dynamics of HMG protein-chromatin interactions in living cells.

Authors:  Gabi Gerlitz; Robert Hock; Tetsuya Ueda; Michael Bustin
Journal:  Biochem Cell Biol       Date:  2009-02       Impact factor: 3.626

Review 9.  Linking oxidative stress to inflammation: Toll-like receptors.

Authors:  Roop Gill; Allan Tsung; Timothy Billiar
Journal:  Free Radic Biol Med       Date:  2010-01-18       Impact factor: 7.376

Review 10.  The high mobility group box: the ultimate utility player of a cell.

Authors:  Christopher S Malarkey; Mair E A Churchill
Journal:  Trends Biochem Sci       Date:  2012-11-13       Impact factor: 13.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.